Gyre Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-39.4M |
| Depreciation & Amortization | $1.8M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $2.5M |
| Net Cash from Operating Activities | $-24.3M |
| Investing Activities | |
| Capital Expenditures | $200.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $9.8M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $47.2M |
| Net Change in Cash | $32.7M |
| Free Cash Flow | $-24.5M |